← Browse by Condition
Medical Condition
synovial sarcoma
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 3, Phase 2
NCT06083883 Phase 1
Recruiting
Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1
Enrollment
44 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT03016819 Phase 3
Recruiting
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
Enrollment
325 pts
Location
United States, China...
Sponsor
Advenchen Laboratories, LLC
NCT06277154 Phase 2
Recruiting
MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma
Enrollment
148 pts
Location
China
Sponsor
HRYZ Biotech Co.